insights_auto
Why is CUE up 68.20%?
Dive Deeperchevron_right
CUE:NASDAQ
Cue Biopharma Inc
$4.76
arrow_upward
+68.20%(+1.93) 1D
$4.96
arrow_upward
+4.19% (+0.20)bedtimeAfter hours
Closed: Nov 18, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CUE...
Open
$3.41
High
$4.77
Low
$3.27
Mkt. cap
39.79M
Avg. vol.
300.14K
Volume
13.14M
52-wk high
$45.50
52-wk low
$2.83
EPS
-$26.99
Beta
2.79
Shares outstanding
8.36M
No. of employees
29
Open
$3.41
High
$4.77
Low
$3.27
Mkt. cap
39.79M
Avg. vol.
300.14K
Volume
13.14M
52-wk high
$45.50
52-wk low
$2.83
EPS
-$26.99
Beta
2.79
Shares outstanding
8.36M
No. of employees
29
News stories
From web sources and news partners
Benzinga
·
6 hours ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga
·
8 hours ago
Dow Falls Over 300 Points; Nvidia Posts Upbeat Earnings
Investing.com
·
10 hours ago
B.Riley cuts Cue Biopharma stock price target on financing concerns
kalkine.ca
·
13 hours ago
Why Did Cue Biopharma (NASDAQ:CUE) Stock Sink After a USD 4.74 Quarterly Loss Per Share?
About Cue Biopharma Inc
CEO-
Employees29
Founded2014
HeadquartersBoston, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Websitecuebiopharma.com